Quick Heal Technologies Ltd
Quick Heal Technologies Q3 FY25: Revenue ₹7.2 Cr
Q3 FY25 earnings call: what management guided on revenue, margins and order book.
The short version
Quick Heal has a healthy pipeline and growing order book, indicating confidence in FY’26 outlook. Q3 FY’25 showed a muted performance with a 4% QoQ revenue decline and 14% YoY decline due to headwinds in consumer and government verticals.
From Quick Heal Technologies Ltd's Q3 FY25 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Quick Heal has a healthy pipeline and growing order book, indicating confidence in FY’26 outlook.
- Enterprise order book has reached material size (₹7.2 crores) with deferred revenue building up (₹10 crores), providing revenue visibility and predictability.
- New product launches like AntiFraud.AI, Seqrite Malware Analysis, and Seqrite Threat Intelligence target emerging enterprise cybersecurity needs, expected to drive future sales.
- DPDP and cybersecurity regulatory compliance expected to boost sales across data privacy and cybersecurity products; average deal size for mid-market ₹75 lakhs to ₹3 crores.
- Consumer segment industry facing de-growth, but Quick Heal plans a flattish revenue trend and increased marketing efforts, e.g. for AntiFraud product.
2 more points from Quick Heal Technologies Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Quick Heal Technologies Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company has made capital expenditure on a Tier 3 data center at their Pune office, involving a significant CAPEX spend.
- Despite this investment, the cash balance remains steady at around Rs. 190 crores.
- There are no specific future capex plans detailed in the call, but the company mentions continuous investments in new product launches like AntiFraud and Horizon 3 categories.
2 more points from Quick Heal Technologies Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in IT - Software
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Quick Heal Technologies Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Quick Heal's enterprise order book as of Q3 FY'25 stands at ₹7.2 crores, a significant increase from ₹35 lakhs at the end of Q2.
- Deferred revenue has grown by around ₹8 crores over the past 9 months, totaling ₹10 crores at the end of Q3 FY'25.
- The order book primarily consists of confirmed purchase orders/contracts, mainly from enterprise customers, domestic and international.
- These orders typically span over contract tenures of 1 to 3 years.
- The order book and deferred revenue are additional to the current quarterly enterprise revenue run rate of around ₹30 crores.
2 more points from Quick Heal Technologies Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Quick Heal Technologies Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹49 Cr, net loss ₹20 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Quick Heal Technologies Ltd's management said in earlier quarters
- Q4 FY25 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q1 FY24 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q4 FY23 earnings call →
- Q3 FY23 earnings call →
- Q2 FY23 earnings call →
Others in IT - Software this season
- All E Technologies Ltd (Q3 FY25)
Cloud adoption growing; 60-65% of product revenue is from cloud solutions, with most new customers opting for cloud. Key concall takeaways from All E…
- C.E. Info Systems Ltd (Q3 FY25)
Past 2 years saw 30%-35% growth, but percentage growth slows as base grows. Key concall takeaways from C.E. Info Systems Ltd's Q3 FY25 earnings call — and how…
- Latent View Analytics Ltd (Q3 FY25)
Pricing increases historically yield 3%-4% growth, factored cautiously given economic uncertainties. Key concall takeaways from Latent View Analytics Ltd's Q3…
- Happiest Minds (Q3 FY25)
Cash EPS showed good year-over-year growth (12.6% last quarter), with annualized Cash EPS at ₹24.6. Key concall takeaways from Happiest Minds Technologies…
Arthneeti Pro · Annual
Quick Heal Technologies Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Quick Heal Technologies Ltd Q3 FY25 results?
Quick Heal has a healthy pipeline and growing order book, indicating confidence in FY’26 outlook. Q3 FY’25 showed a muted performance with a 4% QoQ revenue decline and 14% YoY decline due to headwinds in consumer and government verticals.
What is Quick Heal Technologies Ltd share price analysis?
Quick Heal Technologies Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹830 Cr. Investors should review the full earnings analysis for detailed insights.
Is Quick Heal Technologies Ltd planning capital expenditure?
The company has made capital expenditure on a Tier 3 data center at their Pune office, involving a significant CAPEX spend. - Despite this investment, the cash balance remains steady at around Rs.
Keep Quick Heal Technologies Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.